FDA Warns Two Indian Drugmakers for Manufacturing Practices

Aug 26, 2013


The US drug regulator has issued warning letters to Indian drugmakers Promed Exports and Posh Chemicals for violation of good manufacturing practices, raising to six the number of Indiabased drugmaking facilities against which action has been taken in the past three months. 

Indian drug manufacturing sites account for over 60% of all such warning letters sent out globally by the US Center for Drug Evaluation and Research (CDER) in the past three months. Read more
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments